Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Expands Patient Input To New Area: Orphan Grant Applications

Mar 03 2019

• By Derrick Gingery

FDAEntrance_1200x675

Related Content

FDA Ends Regularly Scheduled Patient-Focused Drug Development Meetings

Sep 29 2017

Master Protocols Are Both Welcome And Inevitable – US FDA's Woodcock

Jul 07 2017

Reliance On ‘Digitized Paper’ Is Slowing Drug Development – US FDA’s Woodcock

Nov 15 2018

US FDA Appoints Another Orphan Products Development Office Head Amid Growth Expectations

Oct 15 2018

From Listening To Advising: The Maturation Of US FDA's Patient-Focused Drug Development Program

Jan 09 2018

US FDA/NORD Partnership Will Further Increase Patient Involvement In Drug Development

Feb 28 2018

US FDA Targets Migraine, Schizophrenia And Opioid Sparing Drugs For Clinical Outcome Assessment Development

Feb 26 2019

FDA’s Patient-Focused Drug Development Meetings Inspire Imitators

May 19 2014

Rare Disease Integration Into FDA Reviews Will Grow Under PDUFA VI

Jul 18 2016

Additional Topics

United States Rare Diseases FDA Regulation BioPharmaceutical

More from Rare Diseases

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window